EchoGo Pro vs Cardiomo
AI Verdict
Choose EchoGo Pro if…
Choose EchoGo Pro if your clinical setting requires an FDA-cleared, AI-powered cloud solution for automated stress echocardiography analysis to improve the diagnosis of coronary artery disease. This tool is ideal for cardiologists and imaging departments seeking near-instant, accurate reports and seamless integration with existing PACS and clinical workflows to enhance diagnostic accuracy and reduce misdiagnosis.
View EchoGo Pro →Choose Cardiomo if…
Choose Cardiomo if you need a medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, particularly for detecting cardiovascular diseases and providing timely alerts to users and caregivers. This tool is well-suited for remote patient monitoring programs, geriatric care, or individuals needing ongoing vital sign tracking (ECG, heart rate, respiration, skin temperature) with real-time notifications and fall detection.
View Cardiomo →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EchoGo Pro | Cardiomo |
|---|---|---|
| Pricing | Contact vendor for pricing | Contact for pricing |
| Deployment | Cloud-based (SaaS) | Cloud-based with wearable device and mobile app |
| FDA Status | 1 AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
EchoGo ProEchoGo Pro is a cloud-based SaaS solution that requires no software installation or extensive training, and integrates seamlessly with existing clinical workflows and PACS. Cardiomo, while aiming for user-friendliness with its wearable patch and mobile app, involves a physical device that needs to be worn and recharged, and its app requires download and connection via Bluetooth.
Clinical Value
EchoGo ProEchoGo Pro is an FDA-cleared AI-powered solution that has been validated in trials, demonstrating over 90% diagnostic performance for coronary artery disease and significantly reducing misdiagnoses. Cardiomo is a medical-grade wearable for continuous monitoring and disease detection, but its clinical validation outcomes, while promising for arrhythmia detection, are often from smaller, short-term studies, and it is currently undergoing FDA approval.
Pricing & Value
TieBoth tools require contacting the vendor for current pricing, making direct comparison difficult. EchoGo Pro offers a subscription or pay-per-use model, with reimbursement codes available for related products. Cardiomo previously had a public price with a monthly subscription, but current details are not available, and its value proposition is tied to remote monitoring and early alerts.
Enterprise Readiness
EchoGo ProEchoGo Pro is a cloud-based SaaS solution designed for seamless integration with existing clinical workflows, including DICOM and HL7, and is compatible with any PACS. It is also deployed in multiple countries and has established partnerships. Cardiomo, while HIPAA compliant and cloud-based, focuses on individual patient monitoring via a wearable and mobile app, which may present different integration challenges for large-scale enterprise deployment compared to an imaging analysis solution.
Innovation
EchoGo ProEchoGo Pro is highlighted as a 'world-first' AI-powered, outcomes-driven decision support tool for automated stress echocardiography analysis, leveraging novel features and machine learning algorithms to improve CAD diagnosis. Cardiomo offers innovative continuous remote monitoring with a medical-grade wearable and AI-powered alerts, but the core technology of wearables for cardiac monitoring is a more established area, even with its advanced features.
Support & Docs
TieBoth companies provide contact information for support. EchoGo Pro has a clinician user manual and offers dedicated support and customer success teams. Cardiomo's information suggests a focus on user and caregiver alerts and a mobile app, implying support for those interfaces, but detailed documentation or support structures are not explicitly outlined in the provided information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EchoGo Pro | Cardiomo |
|---|---|---|
| Product Name | EchoGo Pro | Cardiomo |
| Company | Ultromics | Cardiomo, Inc. |
| Description | EchoGo Pro is an FDA-cleared, AI-powered cloud solution by Ultromics that automates stress echocardiography analysis to improve the diagnosis of coronary artery artery disease, providing near-instant, accurate reports. | Cardiomo offers a medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, designed to detect cardiovascular diseases and provide timely alerts to users and caregivers. |
| Key Features | AI-powered automated echocardiogram analysis, Cloud-based service for accessibility and scalability, Automated identification of coronary artery disease (CAD), Provides near-instant, comprehensive reports, Improves diagnostic accuracy and reduces misdiagnosis, Vendor-neutral system, compatible with any PACS, Seamless integration with existing clinical workflows (DICOM, HL7), SaaS model requires no software installation or extensive training | Medical-grade wearable patch, Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature), AI-powered disease detection (arrhythmias, cardiovascular events), Real-time alerts and notifications, Mobile application (Android and iOS), HIPAA-compliant cloud analytics, Fall detection, Long battery life (up to 7-10 days) |
| Specialties | Cardiology | Cardiology, Geriatrics, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring EchoGo Pro and Cardiomo.